Zobrazeno 1 - 10
of 39
pro vyhledávání: '"S. N. Mosolov"'
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 1, Pp 45-51 (2022)
Over the past two years, healthcare workers have been daily saving patients diagnosed with COVID-19 in life-threatening conditions. These circumstances contribute to an increase in the psychopathological disorders in this social group. However, today
Externí odkaz:
https://doaj.org/article/85561e6ec2094a0081d989a5d0678b72
Autor:
A. G. Poydasheva, D. O. Sinitsyn, I. S. Bakulin, N. A. Suponeva, N. V. Maslennikov, E. E. Tsukarzi, S. N. Mosolov, M. A. Piradov
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 11, Iss 4, Pp 44-50 (2019)
High-frequency repetitive transcranial magnetic stimulation (rTMS) is approved by the Food and Drug Administration (FDA) for the treatment of pharmacotherapy-resistant depressive disorders (DD). Individual target determination for stimulation can be
Externí odkaz:
https://doaj.org/article/875604195937475bae43b6845c0c2dd5
Autor:
E. G. Kostyukova, P. V. Ryvkin, P. V. Alfimov, A. A. Shafarenko, L. A. Andreychik, L. A. Burygina, S. N. Mosolov
Publikováno v:
Psikhiatriya. 20:14-26
Background: Comparative studies of monotherapy with second-generation antipsychotics (SGA) or mood stabilizers in the prevention therapy of Bipolar Disorder (BD) relapses, including those with psychotic symptoms, have not been conducted. Objective: a
Publikováno v:
Psikhiatriya. 19:61-75
Background: The neuronal correlates of depression with mixed traits (according to DSM-5) at rest have not been studied. Objective: to determine the indicators of imaginary coherence of EEG-rest, which distinguish patients with depression with mixed f
Autor:
S. N. Mosolov, E. E. Tsukarzi, I. S. Bakulin, Dmitry O. Sinitsyn, N. A. Suponeva, N. V. Maslennikov, M. A. Piradov, Alexandra G. Poydasheva
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 11, Iss 4, Pp 44-50 (2019)
High-frequency repetitive transcranial magnetic stimulation (rTMS) is approved by the Food and Drug Administration (FDA) for the treatment of pharmacotherapy-resistant depressive disorders (DD). Individual target determination for stimulation can be
Autor:
S N Mosolov
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 120:7
The WHO declared COVID-19 pandemic, the deterioration of the epidemic situation in Russia, the lockdown and the growing fear in society caused by panic rumors and misinformation spread on social networks and the media pose urgent organizational and m
Autor:
S N Mosolov, E G Kostyukova
Publikováno v:
Терапевтический архив, Vol 79, Iss 10, Pp 25-31 (2004)
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 112(11 Pt 2)
The analysis of modern Russian and world literature on the diagnosis and treatment of a depressive phase of bipolar affective disorder (BAD) is presented. Studies on the efficacy of different groups of drugs (antidepressants, mood stabilizers, antips
Autor:
S N, Mosolov
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 112(11 Pt 2)
A review of the recent data on the biological mechanisms of depression, including the мonoamine hypothesis, the diathesis-stress model and the chronobiological model, is presented. These and other biological hypotheses are viewed in the aspect of th
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 116:34
It is known affective disorders are changing the perception of time. The study of time perception in patients with affective disorders enables researchers to make early diagnostic criteria for these conditions, as well as to shed light on possible me